204 related articles for article (PubMed ID: 25249260)
21. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
[TBL] [Abstract][Full Text] [Related]
22. Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer.
Hisamatsu Y; Tokunaga E; Yamashita N; Akiyoshi S; Okada S; Nakashima Y; Aishima S; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Apr; 19(4):1145-52. PubMed ID: 21984487
[TBL] [Abstract][Full Text] [Related]
23. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Clin Breast Cancer; 2013 Apr; 13(2):133-9. PubMed ID: 23246269
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for triple-negative breast cancer patients receiving preoperative systemic chemotherapy.
Asaga S; Kinoshita T; Hojo T; Suzuki J; Jimbo K; Tsuda H
Clin Breast Cancer; 2013 Feb; 13(1):40-6. PubMed ID: 23103363
[TBL] [Abstract][Full Text] [Related]
25. Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: outcomes by receptor status/race/age: analysis using the NCI Surveillance, Epidemiology, and End Results (SEER) database.
Yan W; Christos P; Nori D; Chao KS; Ravi A
Am J Clin Oncol; 2013 Dec; 36(6):552-7. PubMed ID: 22868241
[TBL] [Abstract][Full Text] [Related]
26. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
27. Ethnicity and breast cancer in Hawaii: increased survival but continued disparity.
Braun KL; Fong M; Gotay C; Pagano IS; Chong C
Ethn Dis; 2005; 15(3):453-60. PubMed ID: 16108306
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer.
Livi L; Meattini I; Saieva C; Franzese C; Di Cataldo V; Greto D; Franceschini D; Scotti V; Bonomo P; Nori J; Sanchez L; Vezzosi V; Bianchi S; Cataliotti L; Biti G
Cancer; 2012 Jul; 118(13):3236-43. PubMed ID: 22028054
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].
Ma JG; Wang NJ; Yu WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1729-32. PubMed ID: 22027778
[TBL] [Abstract][Full Text] [Related]
31. The importance of COX-2 expression as prognostic factor in early breast cancer.
Kargi A; Uysal M; Bozcuk H; Coskun HS; Savas B; Ozdogan M
J BUON; 2013; 18(3):579-84. PubMed ID: 24065467
[TBL] [Abstract][Full Text] [Related]
32. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.
Keegan TH; Press DJ; Tao L; DeRouen MC; Kurian AW; Clarke CA; Gomez SL
Breast Cancer Res; 2013; 15(5):R95. PubMed ID: 24131591
[TBL] [Abstract][Full Text] [Related]
33. Race and the prognostic influence of p53 in women with breast cancer.
Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
[TBL] [Abstract][Full Text] [Related]
34. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer.
Leone J; Hassett MJ; Freedman RA; Tolaney SM; Graham N; Tayob N; Vallejo CT; Winer EP; Lin NU; Leone JP
JAMA Oncol; 2024 Apr; 10(4):508-515. PubMed ID: 38421673
[TBL] [Abstract][Full Text] [Related]
35. Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.
Wo JY; Chen K; Neville BA; Lin NU; Punglia RS
J Clin Oncol; 2011 Jul; 29(19):2619-27. PubMed ID: 21606424
[TBL] [Abstract][Full Text] [Related]
36. Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years.
Cortesi L; Marcheselli L; Guarneri V; Cirilli C; Braghiroli B; Toss A; Sant M; Ficarra G; Conte PF; Federico M
Int J Cancer; 2013 Jan; 132(2):E58-65. PubMed ID: 22915138
[TBL] [Abstract][Full Text] [Related]
37. The effect of body mass index and weight change on epithelial ovarian cancer survival in younger women: a long-term follow-up study.
Tyler CP; Whiteman MK; Zapata LB; Hillis SD; Curtis KM; McDonald J; Wingo PA; Kulkarni A; Marchbanks PA
J Womens Health (Larchmt); 2012 Aug; 21(8):865-71. PubMed ID: 22663301
[TBL] [Abstract][Full Text] [Related]
38. cMET and phospho-cMET protein levels in breast cancers and survival outcomes.
Raghav KP; Wang W; Liu S; Chavez-MacGregor M; Meng X; Hortobagyi GN; Mills GB; Meric-Bernstam F; Blumenschein GR; Gonzalez-Angulo AM
Clin Cancer Res; 2012 Apr; 18(8):2269-77. PubMed ID: 22374333
[TBL] [Abstract][Full Text] [Related]
39. Effect of large tumor size on cancer-specific mortality in node-negative breast cancer.
Yu KD; Jiang YZ; Chen S; Cao ZG; Wu J; Shen ZZ; Shao ZM
Mayo Clin Proc; 2012 Dec; 87(12):1171-80. PubMed ID: 23218085
[TBL] [Abstract][Full Text] [Related]
40. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study.
Liu Y; Tamimi RM; Collins LC; Schnitt SJ; Gilmore HL; Connolly JL; Colditz GA
Breast Cancer Res Treat; 2011 Aug; 129(1):175-84. PubMed ID: 21390493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
